Myeloma, Malignant
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| European Rare Blood Disorders Platform (ENROL) (NCT06250595) | Hospital Universitari Vall d'Hebron Research Institute | 2022-07-01 |
Track Myeloma, Malignant automatically
Every clearance here is in the API, with alerts when new ones post.